Portal de Periódicos da CAPES

Myocardial infarction redefined—A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction

2000; Oxford University Press; Volume: 21; Issue: 18 Linguagem: Inglês

10.1053/euhj.2000.2305

1522-9645

Joseph S. Alpert, EM Antman, Fred S. Apple, Paul W. Armstrong, Jean‐Pierre Bassand, Andrea Luna, G A Beller, G. Breithardt, Bernard R. Chaitman, Peter Clemmensen, Erling Falk, Michael C. Fishbein, Marcello Galvani, Arthur Garson, Cindy L. Grines, Christian W. Hamm, Bad Nauheim, Uta C. Hoppe, Allan S. Jaffe, Hugo A. Katus, J. Kjeksus, W Klein, P. Klootwijk, C. Lenfant, Daniel Levy, R. I. Levy, Russell V. Luepker, F I Marcus, Ulf Näslund, Marcus Öhman, Olle Pahlm, P A Poole-Wilson, Radu A. Popp, Kalevi Pyörälà, Jan Ravkilde, N Rehnquist, William L. Roberts, Richard Roberts, Jos R.T.C. Roelandt, Lars Rydén, Susana Sans, Maarten L. Simoons, Kristian Thygesen, Hugh Tunstall‐Pedoe, Richard Underwood, Barry F. Uretsky, Frans Van de Werf, L M Voipio-Pulkki, Galen S. Wagner, Lars Wallentin, William Wijns, David A. Wood,

Cardiac electrophysiology and arrhythmias

This document was developed by a consensus conference initiated by Kristian Thygesen, MD, and Joseph S. Alpert, MD, after formal approval by Lars Rydén, MD, President of the European Society of Cardiology (ESC), and Arthur Garson, MD, President of the American College of Cardiology (ACC). All of the participants were selected for their expertise in the field they represented, with approximately one-half of the participants selected from each organization. Participants were instructed to review the scientific evidence in their area of expertise and to attend the consensus conference with prepared remarks. The first draft of the document was prepared during the consensus conference itself. Sources of funding appear in Appendix A. The recommendations made in this document represent the attitudes and opinions of the participants at the time of the conference, and these recommendations were revised subsequently. The conclusions reached will undoubtedly need to be revised as new scientific evidence becomes available. This document has been reviewed by members of the ESC Committee for Scientific and Clinical Initiatives and by members of the Board of the ESC who approved the document on April 15, 2000.*